[Evaluation of the final stature reached by type 1 diabetes mellitus patients followed at an outsourced service].
Metabolic changes resulting from type 1 diabetes mellitus (DM1) may put growth and development at risk.


OBJECTIVE
To evaluate the final stature of DM1 patients and the interference of DM1 in growth.


METHODS
The final height reached by 58 DM1 patients was evaluated according to anthropometric data and metabolic control.


RESULTS
Mean age was 26.4 years (15.0-51.0) and the duration of disease was of 9.6 years (1.4-25.0). Final stature was 165.1 cm (149.3-183.0) and the z-score for height was 0.09 (-1.76-2.85). In a subgroup (n = 34), it was possible to evaluate the effect of metabolic control on growth. Mean glycosylated hemoglobin was 12.2% (6.8-24.1) and the correlation between anthropometric data and glucose control was not considered statistically significant (p > 0.05).


CONCLUSIONS
We conclude that DM1 had no effect on the final stature, to the detriment of a poor metabolic control.
Oliveira
Raphael Augusto Gomes de
RA
Departamento de Clínica Médica, Universidade Federal do Triângulo Mineiro, Uberaba, MG, Brasil.
Ferreira
Beatriz Pires
BP
Palhares
Heloísa Marcelino Cunha
HM
Silva
Adriana Paula da
AP
Borges
Maria de Fátima
Mde F
D000293:Adolescent; D000328:Adult; D001827:Body Height / Q000502:physiology*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000150:complications*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006130:Growth Disorders / Q000175:diagnosis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020416:Outsourced Services; D018709:Statistics, Nonparametric; D013997:Time Factors; D055815:Young Adult
D006442:Glycated Hemoglobin